Ocular Therapeutix Garners $14,000,000 Series D Round

  • Feed Type
  • Date
  • Company Name
    Ocular Therapeutix
  • Mailing Address
    36 Crosby Dr. Bedford, MA 01730
  • Company Description
    Ocular Therapeutix, Inc. is a privately held company focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology and ophthalmic surgery.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series D
  • Proceeds Purposes
    The funding will be used to support Ocular Therapeutix’s Phase II clinical trials across a variety of therapeutic areas. The first trial will be conducted to reinforce safety and test efficacy of their first sustained drug delivery system, a moxifloxacin-loaded punctum plug.
  • M&A Terms
  • Venture Investor
    Ascension Health Ventures
  • Venture Investor
    Polaris Venture Partners
  • Venture Investor
    SV Life Sciences
  • Venture Investor
    Versant Ventures

Trending on Xconomy